id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
clinmedi-179	Kawase, Kazumi; Yoshida, Kazuhiko; Hara, Keigo; Hidaka, Suguru; Takeyama, Hiroshi	Efficacy and safety of neoadjuvant chemotherapy with dose de-escalation tri-weekly nanoparticle albumin-bound paclitaxel and FEC for human epidermal growth factor receptor 2-positive breast cancer	2023	9	.pdf	application/pdf	4152	224	57	Currently, the standard treatment for breast cancer is NAC consisting of an anthracycline and taxane- based regimens. The aim of this study was to examine the effects of tri-weekly low-dose nab-PTX with anti-HER2 drugs followed by fluorouracil, epirubicin, and cyclophosphamide (FEC) as NAC in patients with HER2 + breast cancer.	cache/clinmedi-179.pdf	txt/clinmedi-179.txt